登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
UNSPSC Code:
41106514
Biological source:
human blood
Relevant disease(s):
cancer
Growth mode:
Suspension
Karyotype:
Complex translocations, refer to Karpas et al., 2005
Morphology:
Single round to polymorphic cells growing in suspension
biological source
human blood
packaging
tube of 5 μg 06100302-DNA-5UG, pkg of vial of cells 06100302-1VL
growth mode
Suspension
karyotype
Complex translocations, refer to Karpas et al., 2005
morphology
Single round to polymorphic cells growing in suspension
products
Secretes IgGks
receptors
Not specified
technique(s)
cell culture | mammalian: suitable
relevant disease(s)
cancer
shipped in
dry ice
storage temp.
-140 to -196°C
Biochem/physiol Actions
Established from the peripheral blood of a 56 year-old male diagnosed with multiple myeloma.
Human myeloma
Not specified
Preparation Note
Maintain cultures between 0.5 - 2 x 1000,000 cells/ml; 5% CO2; 37 °C. Doubling time approximately 60 hours. Split saturated culture 1:2 every 2-4 days. Round to polymorhpic cells growing singly or in small clusters in suspension.
RPMI 1640 + 2 mM Glutamine + 10% Fetal Bovine Serum (FBS).
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by commercial organizations may require a license agreement. Commercial customers will be contacted by cellscreening@merckgroup.com to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to culturecollections@ukhsa.gov.uk.
Disclaimer
This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.
法规信息
新产品
此项目有